If you need more lookups,
subscriptions start at $34 USD/month.
David Venables Location
United Kingdom
David Venables Work
CEO @ (August 2021 - Present)
Chair @ (September 2021 - Present)
Non Executive Director @ (October 2021 - Present)
Non Executive Director @ (March 2023 - Present)
Managing Director @ BioMelior Services Ltd (May 2013 - Present)
Honorary Professor, College of Medicine and Veterinary Medicine @ (May 2021 - Present)
President, AskBio Europe @ (January 2020 - August 2021)
CEO @ (October 2014 - January 2020)
VP - CMC @ NightstaRx (August 2013 - June 2015)
CEO @ (October 2013 - February 2015)
Non Executive Director @ Ark Therapeutics Plc (April 2013 - February 2015)
CEO @ Ark Therapeutics Plc (August 2012 - February 2015)
Executive Director - Manufacturing Services @ Ark Therapeutics Plc (April 2012 - August 2012)
Chief Operating Officer @ Intercell USA Inc (February 2010 - June 2012)
Site Operations Director @ Intercell Biomedical Ltd (September 2007 - February 2010)
Director of Operations, BioReliance Europe @ (May 2004 - September 2007)
Director of Market Development, Global Manufacturing @ (October 2003 - April 2004)
Director of Operations, BioManufacturing @ Q1 Biotech (April 2002 - September 2003)
Head of Biotechnology @ Covance Laboratories (October 1998 - April 2002)
Group Leader, Process Development @ Medeva (October 1993 - October 1998)
David Venables Education
University of Surrey
PhD
1990-1993
University of Surrey
Honours
1986-1990
David Venables Skills
Biopharmaceuticals
Vaccines
GMP
Gene Therapy
FDA
Virology
Life Sciences
Biotechnology
CRO
Commercialization
Lifesciences
Technology Transfer
Product Development
R&D
Drug Development
Strategy
Cell Culture
Manufacturing
Pharmaceutical Industry
Validation
Molecular Biology
Cell
Clinical Development
Protein Chemistry
Monoclonal Antibodies
Fermentation
Microbiology
Public Speaking
Process Improvement
Development
Microsoft Excel
Leadership
Business Strategy
Market Development
David Venables Summary
David Venables, based in United Kingdom, is currently a CEO at Laverock Therapeutics. David Venables brings experience from previous roles at Concinnity Genetics, Axol Bioscience Ltd., NovalGen and BioMelior Services Ltd. David Venables holds a 1990 - 1993 PhD @ University of Surrey. With a robust skill set that includes Biopharmaceuticals, Vaccines, GMP, Gene Therapy, FDA and more. David Venables has 5 emails and 1 mobile phone numbers on RocketReach.
Looking for a different David Venables?
Find contact details for 700 million professionals.